| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Fadraciclib |
CYC-065 |
1070790-89-4 |
詳細
|
| YKL-5-124 TFA |
|
2748220-93-9 |
詳細
|
| Trilaciclib |
曲拉西利 |
1374743-00-6 |
詳細
|
| Trilaciclib hydrochloride |
曲拉西利雙鹽酸鹽 |
1977495-97-8 |
詳細
|
| Cdc7-IN-1 |
CDC7-IN-1 (COMPOUND 13) |
1402055-25-7 |
詳細
|
| MSC2530818 |
MSC2530818 |
1883423-59-3 |
詳細
|
| CDK9-IN-8 |
CDK9-IN-8 |
2105956-51-0 |
詳細
|
| Enitociclib |
1610358-56-9 |
1610358-56-9 |
詳細
|
| (±)-Enitociclib |
1610358-53-6 |
1610358-53-6 |
詳細
|
| (-)-Enitociclib |
(-)-BAY-1251152 |
1610358-59-2 |
詳細
|
| CLK1-IN-1 |
2123491-32-5 |
2123491-32-5 |
詳細
|
| CDK8-IN-1 |
CDK8-IN-1 |
1629633-48-2 |
詳細
|
| THZ531 |
THZ531 |
1702809-17-3 |
詳細
|
| CK7 |
CDK2/9 INHIBITOR |
507487-89-0 |
詳細
|
| Milciclib |
PHA-848125 |
802539-81-7 |
詳細
|
| Bisindolylmaleimide X hydrochloride |
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE) |
145317-11-9 |
詳細
|
| CC-671 |
CC-671 |
1618658-88-0 |
詳細
|
| PHA-793887 |
3-甲基-N-[1,4,5,6-四氫-6,6-二甲基-5-[(1-甲基-4-哌啶基)甲酰基]吡咯并[3,4-C]吡唑-3-基]丁酰胺 |
718630-59-2 |
詳細
|
| CDK8-IN-4 |
CDK8-IN-4 |
1613638-82-6 |
詳細
|
| AZD4573 |
AZD4573 |
2057509-72-3 |
詳細
|
| CDK12-IN-3 |
CDK12-IN-3 |
2220184-50-7 |
詳細
|
| Lerociclib dihydrochloride |
LEROCICLIB HCL ; G1T38 DIHYDROCHLORIDE ; G1T 38 DIHYDROCHLORIDE |
2097938-59-3 |
詳細
|
| PNU112455A hydrochloride |
N4-(6-AMINOPYRIMIDIN-4-YL)-SULFANILAMIDE HCL |
21886-12-4 |
詳細
|
| CDK12-IN-2 |
化合物CDK12-IN-2 |
2244987-03-7 |
詳細
|
| MBQ-167 |
MBQ 167;MBQ167 |
2097938-73-1 |
詳細
|
| CDK4/6-IN-2 |
CDK4/6-IN-2 |
1800506-48-2 |
詳細
|
| CDK12-IN-E9 |
CDK12 inhibitor E9 S-isomer |
2020052-55-3 |
詳細
|
| NVP-2 |
化合物NVP-2 |
1263373-43-8 |
詳細
|
| BRD6989 |
BRD6989 |
642008-81-9 |
詳細
|
| DRAK2-IN-1 |
DRAK2-IN-1 |
871837-60-4 |
詳細
|
| THZ2 |
THZ2 |
1604810-84-5 |
詳細
|
| SRI-29329 |
化合物SRI-29329 |
2086809-58-5 |
詳細
|
| CDK5 inhibitor 20-223 |
CDK5 INHIBITOR 20-223 |
865317-30-2 |
詳細
|
| THAL-SNS-032 |
THAL-SNS-032 |
2139287-33-3 |
詳細
|
| Voruciclib |
VORUCICLIB |
1000023-04-0 |
詳細
|
| hSMG-1 inhibitor 11e |
化合物T35529 |
1402452-10-1 |
詳細
|
| CPS2 |
化合物 CPS2 |
2756741-90-7 |
詳細
|
| AZ5576 |
化合物AZ5576 |
2751721-40-9 |
詳細
|
| dCeMM2 |
化合物 DCEMM2 |
296771-07-8 |
詳細
|
| CDK9-IN-7 |
CDK9-IN-7 |
2369981-71-3 |
詳細
|
| Mevociclib |
SY-1365 |
1816989-16-8 |
詳細
|
| Atuveciclib S-Enantiomer |
Atuveciclib S-Enantiomer |
250279-81-1 |
詳細
|
| PROTAC CDK2/9 Degrader-1 |
|
2408641-24-5 |
詳細
|
| BS-181 hydrochloride |
BS181 |
1397219-81-6 |
詳細
|
| CKI-7 free base |
CKI-7 |
120615-25-0 |
詳細
|
| Ipivivint |
IPIVIVINT |
1481617-15-5 |
詳細
|
| KB-0742 dihydrochloride |
KB-0742 dihydrochloride |
2416874-75-2 |
詳細
|
| SY-5609 |
7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈 |
2417302-07-7 |
詳細
|
| BSJ-4-116 |
化合物BSJ-4-116 |
2519823-34-6 |
詳細
|
| CDK4/6-IN-6 |
CDK4/6-IN-6 |
2380321-51-5 |
詳細
|
| CD73-IN-4 |
化合物CD73-IN-4 |
2216764-29-1 |
詳細
|
| LY3177833 |
CS-2783 |
1627696-51-8 |
詳細
|
| CD73-IN-3 |
5-[6-甲基-5-[(1S,2R)-2-丙-2-基環(huán)丙基]噠嗪-3-基]-1H-嘧啶-2,4-二酮 |
2375815-63-5 |
詳細
|
| Uliledlimab |
尤萊利單抗 |
2378407-27-1 |
詳細
|
| Mupadolimab |
莫帕利單抗 |
2451856-97-4 |
詳細
|
| Riviciclib hydrochloride |
P276-00 |
920113-03-7 |
詳細
|
| CDK7/12-IN-1 |
化合物 CDK7/12-IN-1 |
2654075-94-0 |
詳細
|
| CDK9-IN-2 |
N2'-(反式-4-氨基環(huán)己基)-5'-氯-N6-[(3-氟苯基)甲基]-[2,4'-聯(lián)吡啶]-2',6-二胺 |
1263369-28-3 |
詳細
|
| Palbociclib-d8 |
帕博西尼-D8 |
1628752-83-9 |
詳細
|
| AT7519 |
4-[(2,6-二氯芐基)氨基]-N-4-哌啶1H-吡唑-3-羧胺 |
844442-38-2 |
詳細
|
| AT7519 Hydrochloride |
N-(4-哌啶基)-4-(2,6-二氯芐氨基)-1H-吡唑-3-羧胺鹽酸鹽 |
902135-91-5 |
詳細
|
| TNIK-IN-3 |
化合物TNIK-IN-3 |
2754265-25-1 |
詳細
|
| Eciruciclib |
化合物 ECIRUCICLIB |
1868086-40-1 |
詳細
|
| WEE1-IN-5 |
化合物DEBIO-0123 |
2243882-74-6 |
詳細
|
| AUZ 454 |
K03861 |
853299-07-7 |
詳細
|
| CP681301 |
化合物 CP681301 |
865317-32-4 |
詳細
|
| NG 52 |
2-[[6-[(3-氯苯基)氨基]-9-異丙基-9H-嘌呤-2-基]氨基]乙醇 |
212779-48-1 |
詳細
|
| XL413 hydrochloride |
XL413 HYDROCHLORIDE |
2062200-97-7 |
詳細
|
| BMS-265246 |
BMS265246 |
582315-72-8 |
詳細
|
| CVT-313 |
CVT 313 |
199986-75-9 |
詳細
|
| Senexin A |
SENEXIN A |
1366002-50-7 |
詳細
|
| Ribociclib hydrochloride |
7-環(huán)戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺鹽酸鹽 |
1211443-80-9 |
詳細
|
| Ribociclib succinate |
LEE011 琥珀酸鹽 |
1374639-75-4 |
詳細
|
| Ribociclib succinate hydrate |
瑞柏司可里布(RIBOCICLIB LEE011)琥珀酸鹽水合物 |
1374639-79-8 |
詳細
|
| HS38 |
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide |
1030203-81-6 |
詳細
|
| Abemaciclib methanesulfonate |
LY2835219 |
1231930-82-7 |
詳細
|
| Abemaciclib |
阿貝西利 |
1231929-97-7 |
詳細
|
| 6-(Dimethylamino)purine |
6-二甲基氨基嘌呤 |
938-55-6 |
詳細
|
| NCT02 |
2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺 |
790245-61-3 |
詳細
|
| KH-CB20 |
|
1354448-60-4 |
詳細
|
| Longdaysin |
9H-Purin-6-aMine, 9-(1-Methylethyl)-N-[[3-(trifluoroMethyl)phenyl]Methyl]- |
1353867-91-0 |
詳細
|
| Rintodestrant |
RINTODESTRANT |
2088518-51-6 |
詳細
|
| FN-1501 |
1429515-59-2 |
1429515-59-2 |
詳細
|
| (E/Z)-Zotiraciclib hydrochloride |
化合物 (E/Z)-ZOTIRACICLIB HYDROCHLORIDE |
1321626-25-8 |
詳細
|
| 5-Iodo-indirubin-3'-monoxime |
5-IODO-INDIRUBIN-3'-MONOXIME |
331467-03-9 |
詳細
|
| hSMG-1 inhibitor 11j |
嘧啶雜質(zhì)1 |
1402452-15-6 |
詳細
|
| RGB-286638 |
N-[1,4-二氫-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-嗎啉基脲鹽酸鹽 |
784210-87-3 |
詳細
|
| HS-243 |
HS-243 |
848249-10-5 |
詳細
|
| Indirubin-3′-oxime |
(2Z,3E)-3-(羥基亞氨基)-[2,3'-聯(lián)吲哚啉亞基]-2'-酮 |
667463-82-3 |
詳細
|
| NGR peptide |
細胞穿膜肽 NGR PEPTIDE |
651328-78-8 |
詳細
|
| NVP 231 |
NVP-231 |
362003-83-6 |
詳細
|
| Anacetrapib |
安塞曲匹 |
875446-37-0 |
詳細
|
| Dalcetrapib |
CETP抑制劑 |
211513-37-0 |
詳細
|
| Narazaciclib |
8-環(huán)戊基-7,8-二氫-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
詳細
|
| Aminopurvalanol A |
AMINOPURVALANOL A |
220792-57-4 |
詳細
|
| CDKI-73 |
CS-2259 |
1421693-22-2 |
詳細
|
| SR-4835 |
SR-4835 |
2387704-62-1 |
詳細
|
| NSC 107512 |
化合物 NSC 107512 |
22242-89-3 |
詳細
|
| SU9516 |
SU 9516 |
377090-84-1 |
詳細
|
| DB1113 |
|
2769753-53-7 |
詳細
|